Protocol PVD-202: A Phase 2, Randomized, Double-Masked, Placebo-Controlled Multicenter Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD in Non-Proliferative Diabetic Retinopathy

Trial Profile

Protocol PVD-202: A Phase 2, Randomized, Double-Masked, Placebo-Controlled Multicenter Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD in Non-Proliferative Diabetic Retinopathy

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 06 Apr 2017

At a glance

  • Drugs ALG 1001 (Primary)
  • Indications Diabetic retinopathy
  • Focus Therapeutic Use
  • Acronyms PACIFIC
  • Sponsors Allegro Ophthalmics
  • Most Recent Events

    • 03 Oct 2016 Status changed from recruiting to active, no longer recruiting, as reported in an Allegro Ophthalmics media release.
    • 03 Oct 2016 According to an Allegro Ophthalmics media release, last patient has been enrolled in this trial. Top-line results from this trial are anticipated within the first half of 2017.
    • 06 May 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top